Australian Shares Slide Despite Tech Stocks Rally; Mayne Pharma to be Acquired by Cosette in AU$672 Million Deal

MT Newswires Live
02-21

Australian shares slid on Friday's close despite gains from Asian markets fuelled by the rise in tech stocks as Chinese tech firm Alibaba Group Holdings' revenue beat estimates.

The S&P/ASX 200 Index fell 0.3% or 26.6 points to close at 8296.2.

Investors are still cautious of increasing geopolitical tensions until China implements significant structural reforms, any growth surges in stocks are likely to be temporary, Bloomberg reported.

On the domestic front, Australia's jobs data for February does not add any risks to the Reserve Bank of Australia's (RBA) concerns about market labor market tightness despite an increase in employment, ANZ Research said in a note.

Business activity in Australia's private sector rose to a six-month high in February, buoyed by growth in the services sector, according to a monthly survey by S&P Global.

In company news, Mayne Pharma Group (ASX:MYX) entered into a scheme implementation deed to be acquired by Cosette via a scheme of arrangement for AU$7.40 per share, valuing the firm at around AU$672 million. Shares of the pharmaceutical firm rose past 33% at market close.

QBE Insurance Group (ASX:QBE) reported Friday that its 2024 adjusted earnings per diluted share rose to $1.142 from $0.908 a year earlier. Shares of the group past 3% at market close.

Lastly, Domain Holdings Australia (ASX:DHG) received an unsolicited, non-binding proposal from CoStar Group, a Texas-based real estate information analytics firm, to acquire the company's shares at AU$4.20 per share in cash. Shares of the company rose 40% at market close.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10